LON­DON — San­doz is bet­ting big on its new­ly formed biosim­i­lar unit, as it re­veals plans to grow its pipeline there by more than sev­en­fold...

The UK gov­ern­men­t's move to pay more for med­i­cines and fos­ter a clos­er re­la­tion­ship with drug­mak­ers ap­pears to have led to an in­crease in the...

Eu­ro­pean firm Claret Cap­i­tal Part­ners has raised €575 mil­lion in its lat­est round, dubbed Fund IV, and a siz­able por­tion will be lent out to...

Plus, news about Boston Sci­en­tif­ic. 

Lon­za’s new fac­to­ry in the US: Lon­za is ex­pand­ingits US ca­pac­i­ty with a new com­mer­cial spray-dry­ing fa­cil­i­ty in Bend...

The FDA has made per­ma­nent the lead­ers of CDER and CBER, sta­bi­liz­ing key agency posts as a new com­mis­sion­er awaits con­fir­ma­tion.

The de­ci­sion was an­nounced...

A rapid­ly grow­ing out­break of Ebo­la in Africa has prompt­ed a race to de­vel­op new vac­cines against the virus, even as a cru­cial or­ga­ni­za­tion spear­head­ing...